Medtronic gains CE Mark approval for InterStim products


Medtronic which is Irish medical device maker has secured CE Mark approval for its InterStim Micro neurostimulator and InterStim SureScan MRI leads.

By giving full-body MRI scan eligible, lifestyle-friendly choices with InterStim Micro or InterStim II neurostimulators, the firm has enhanced accessibility to sacral neuromodulation (SNM) therapy for European patients.

InterStim Micro is a rechargeable device, which provides sacral neuromodulation therapy to treat overactive bladder (OAB), faecal incontinence (FI) and non-obstructive urinary retention.

InterStim Micro is said to be 80 percent smaller than the already existing recharge-free InterStim II neurostimulator.
The company stated that the offerings will have a life span of 15 years with its Overdrive battery technology.
SureScan leads are present for utilization in both InterStim Microsystem, as well as in upcoming implants of the existing recharge-free InterStim II. It also assists in full-body 1.5 and 3 Tesla MRI-conditional scans.

Medtronic further stated that it is the only firm in Europe to give patients with a choice between rechargeable and recharge-free systems, which are both full-body MRI-conditional.